SCHEMBL14022018

SCHEMBL14022018

COc1cccc(N2CCN(c3cnc4ccc(-c5cncc([S+](N)[O-])c5)cc4n3)CC2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.59
MAPT P10636 5/20 0.59
ALDH1A1 P00352 5/20 0.59
RAB9A P51151 4/20 0.59
SMN1; SMN2 Q16637 3/20 0.46
DHFR P00374 2/20 0.42
ABCG2 Q9UNQ0 1/20 0.40
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
NFKB1 P19838 1/20 0.39
HTT P42858 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
ABL1 P00519 1/20 0.39
NTRK1 P04629 1/20 0.39
YES1 P07947 1/20 0.39
PIM1 P11309 1/20 0.39
MAPK1 P28482 1/20 0.39
KDR P35968 1/20 0.39
HIPK1 Q86Z02 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3095271 0.82 MAPT (0.59) NPC1MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL14022727 0.80 PIK3CD (0.48) ALDH1A1HPGDPIM1KDM4EMEN1
SCHEMBL14021886 0.80 PIK3CB (0.52) ALDH1A1GAAHSD17B10
SCHEMBL14021883 0.78 PIK3CB (0.43) NPC1MAPTALDH1A1RAB9A
SCHEMBL14021881 0.77 PIK3CA (0.42) NPC1MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL3087828 0.76 ALDH1A1 (0.56) NPC1MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL14021877 0.76 PIK3CA (0.43) ALDH1A1GAAHPGDKDM4E
SCHEMBL13276521 0.74 ALDH1A1 (0.60) NPC1MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL3087886 0.73 ALDH1A1 (0.55) NPC1MAPTALDH1A1RAB9ASMN1; SMN2
SCHEMBL12812381 0.72 ALDH1A1 (0.60) NPC1MAPTALDH1A1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008141065-A1 QUINOXALINE DERIVATIVES AS P13 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-11-20 WO disclosed